Printer Friendly

Ballooning-out gets mostly good marks.

Ballooning-out gets mostly good marks

Results from the longest follow-upstudy of patients treated with balloon angioplasty--which opens blocked blood vessels in the heart--indicate that patients still benefit years after the procedure. However, in more than 30 percent of the patients, renarrowing occurs within seven years, necessitating repeat angioplasty or heart surgery, say physicians.

Initial angioplasties on the 169 patientswere done in Zurich, Switzerland, prior to 1981 by Andreas R. Gruentzig, who performed the world's first angioplasty on a human in 1977. By inflating a balloon-tipped catheter inside a blood vessel, cardiologists can spread apart the thickened walls and restore blood flow through the vessel. Designed to open arteries in the heart narrowed by plaque buildup due to atherosclerosis, angioplasty does not require major surgery. Researchers at Emory University School of Medicine in Atlanta and Zurich's University Hospital, who followed Gruentzig's first patients for five to eight years to measure the procedure's long-term success, report the results in the April 30 NEW ENGLAND JOURNAL OF MEDICINE.

Encouraged by the relative noninvasivenessof the procedure and reported successes, more physicians are recommending it in lieu of heart surgery for certain patients. But as the procedure's popularity increases, so do questions about whether it is merely a "stop-gap' measure, postponing inevitable surgery. The Zurich study could put to rest some of those doubts, yet reinforce others.

Six years after initial angioplasty, 79percent of the patients had "event-free survival,' defined by the authors as being alive, free of heart attacks and not having needed coronary bypass surgery. There is, however, a bleaker side to the success story. In 30 percent of the 169 patients, the affected artery became partially blocked again within six months after angioplasty. And more recurrences were observed years later. During the course of the study, repeat angioplasties were needed in 27 patients and coronary bypass surgery in 19 patients. The outcome of an angioplasty also depends on the number of vessels involved, say Spencer B. King III of Emory and his coauthors.

"[Recurrence] is a big concern . . . ofgreat interest to us,' says King. "The point is we need a more potent way to fight stenosis [blockage].' New ways to stop blockage are being tested at Emory and elsewhere, says King. He told SCIENCE NEWS those methods include using drugs to interfere with clotting and placing rigid tubes inside the artery. (Researchers in Switzerland and France recently reported success using stainless steel mesh to prop open arteries.)

At the National Heart, Lung andBlood Institute in Bethesda, Md., a comparison of data from the late 1970s and from 1984-85 indicates that the technique is becoming safer and more effective, says Eugene R. Passamani, an associate director for cardiology. Commenting on the Zurich study, Passamani says it is difficult to make generalizations from a small group of patients, but he calls the long-term results for the most part "reassuring.' The institute is planning randomized trials to compare angioplasty with bypass surgery, says Passamani. "You can make arguments on both sides,' he says. "With angioplasty, it's less invasive and the patient goes home earlier. But it can't do as complete a revascularization.'

In an editorial accompanying theZurich study report, Kenneth M. Kent of Georgetown University Hospital in Washington, D.C., says an estimated 150,000 angioplasties will be done in the United States this year. While concluding that the Zurich data will "contribute to the increasing acceptance' of angioplasty, Kent says that, until comparisons with surgical techniques are completed, decisions must be based on "incomplete information and on clinical judgment.'

Photo: Physicians inflate the end of a balloon-tippedcatheter after guiding it through an artery in the arm or leg and into the coronary arteries. The increased pressure at the site of blockage dilates the blood vessel.
COPYRIGHT 1987 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1987, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:follow-up study on balloon angioplasty
Author:Edwards, Diane D.
Publication:Science News
Date:May 16, 1987
Previous Article:Shotgun approach to genetic engineering.
Next Article:Hereditary factors in AIDS?

Related Articles
Angioplasty deemed unnecessary for many.
Heart choice for diabetics.
Success clearing clogged arteries.
Electronics recycling bill advances.
Frasier makes a run at four.
Marshfield's West keeps nerves in check as he prepares for a spin at state meet.
What we are doing about symptoms that can't be measured easily.
The hunt for antihelium: finding a single heavy antimatter nucleus could revolutionize cosmology.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters